                         SEQUENCE LISTING

<110>  PROMEGA CORPORATION
 
<120>  DUAL PROTECTED PRO-COELENTERAZINE SUBSTRATES

<130>  016026-9576-WO01

<140>  New PCT International Patent Application
<141>  2017-09-08

<150>  US 62/385,701
<151>  2016-09-09

<160>  11    

<170>  PatentIn version 3.3

<210>  1
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  1

Asp Glu Val Asp 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  2

Leu Glu Thr Asp 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  3

Leu Glu His Asp 
1               


<210>  4
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  4

Val Asp Val Ala Asp 
1               5   


<210>  5
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  5

Leu Leu Val Tyr 
1               


<210>  6
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  6

Gln Glu Val Tyr 
1               


<210>  7
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Modified leucine amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Modified leucine amino acid

<400>  7

Leu Pro Leu Asp 
1               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  8

Ile Glu Pro Asp 
1               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  9

Ile Glu Thr Asp 
1               


<210>  10
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  10

Thr Ser Ala Val Leu Gln 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  11

Val Asn Ser Thr Leu Gln 
1               5       


